PubMed

Cardioprotective and anti-inflammatory effects of interleukin converting enzyme inhibition in experimental diabetic cardiomyopathy.

Westermann D, Van Linthout S, Dhayat S, Dhayat N, Escher F, Bücker-Gärtner C, Spillmann F, Noutsias M, Riad A, Schultheiss HP, Tschöpe C.

Diabetes. 2007 Jul;56(7):1834-41. Epub 2007 May 1.PMID: 17473225 [PubMed - indexed for MEDLINE]Related articlesFree article

Anti-inflammatory effects of atorvastatin improve left ventricular function in experimental diabetic cardiomyopathy.

Van Linthout S, Riad A, Dhayat N, Spillmann F, Du J, Dhayat S, Westermann D, Hilfiker-Kleiner D, Noutsias M, Laufs U, Schultheiss HP, Tschöpe C.

Diabetologia. 2007 Sep;50(9):1977-86. Epub 2007 Jun 23.PMID: 17589825 [PubMed - indexed for MEDLINE]Related articles

Chronic inhibition of p38MAPK improves cardiac and endothelial function in experimental diabetes mellitus.

Riad A, Unger D, Du J, Westermann D, Mohr Z, Sobirey M, Dorenkamp M, Schultheiss HP, Tschöpe C.

Eur J Pharmacol. 2007 Jan 5;554(1):40-5. Epub 2006 Sep 14.PMID: 17097634 [PubMed - indexed for MEDLINE]Related articles

Inhibition of p38 mitogen-activated protein kinase attenuates left ventricular dysfunction by mediating pro-inflammatory cardiac cytokine levels in a mouse model of diabetes mellitus.

Westermann D, Rutschow S, Van Linthout S, Linderer A, Bücker-Gärtner C, Sobirey M, Riad A, Pauschinger M, Schultheiss HP, Tschöpe C.

Diabetologia. 2006 Oct;49(10):2507-13. Epub 2006 Aug 26.PMID: 16937126 [PubMed - indexed for MEDLINE]Related articles

Tumor necrosis factor-alpha antagonism protects from myocardial inflammation and fibrosis in experimental diabetic cardiomyopathy.

Westermann D, Van Linthout S, Dhayat S, Dhayat N, Schmidt A, Noutsias M, Song XY, Spillmann F, Riad A, Schultheiss HP, Tschöpe C.

Basic Res Cardiol. 2007 Nov;102(6):500-7. Epub 2007 Oct 5.PMID: 17909696 [PubMed - indexed for MEDLINE]Related articles

Transgenic activation of the kallikrein-kinin system inhibits intramyocardial inflammation, endothelial dysfunction and oxidative stress in experimental diabetic cardiomyopathy.

Tschöpe C, Walther T, Escher F, Spillmann F, Du J, Altmann C, Schimke I, Bader M, Sanchez-Ferrer CF, Schultheiss HP, Noutsias M.

FASEB J. 2005 Dec;19(14):2057-9. Epub 2005 Aug 29.PMID: 16129698 [PubMed - indexed for MEDLINE]Related articlesFree article

Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene.

Tschöpe C, Walther T, Königer J, Spillmann F, Westermann D, Escher F, Pauschinger M, Pesquero JB, Bader M, Schultheiss HP, Noutsias M.

FASEB J. 2004 May;18(7):828-35.PMID: 15117887 [PubMed - indexed for MEDLINE]Related articlesFree article

Chronic endothelin-A receptor antagonism is as protective as angiotensin converting enzyme inhibition against cardiac dysfunction in diabetic rats.

Wölkart G, Pang X, Stessel H, Kirchengast M, Brunner F.

Br J Pharmacol. 2007 Aug;151(8):1187-97. Epub 2007 Jun 18.PMID: 17572700 [PubMed - indexed for MEDLINE]Related articlesFree article

Magnetic resonance imaging analysis of cardiac cycle events in diabetic rats: the effect of angiotensin-converting enzyme inhibition.

Al-Shafei AI, Wise RG, Gresham GA, Carpenter TA, Hall LD, Huang CL.

J Physiol. 2002 Jan 15;538(Pt 2):555-72.PMID: 11790819 [PubMed - indexed for MEDLINE]Related articlesFree article

Contributions of inflammation and cardiac matrix metalloproteinase activity to cardiac failure in diabetic cardiomyopathy: the role of angiotensin type 1 receptor antagonism.

Westermann D, Rutschow S, Jäger S, Linderer A, Anker S, Riad A, Unger T, Schultheiss HP, Pauschinger M, Tschöpe C.

Diabetes. 2007 Mar;56(3):641-6.PMID: 17327431 [PubMed - indexed for MEDLINE]Related articlesFree article

Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy.

Van Linthout S, Seeland U, Riad A, Eckhardt O, Hohl M, Dhayat N, Richter U, Fischer JW, Böhm M, Pauschinger M, Schultheiss HP, Tschöpe C.

Basic Res Cardiol. 2008 Jul;103(4):319-27. Epub 2008 Mar 17.PMID: 18347835 [PubMed - indexed for MEDLINE]Related articles

Noninvasive evaluation of cardiac dysfunction by echocardiography in streptozotocin-induced diabetic rats.

Hoit BD, Castro C, Bultron G, Knight S, Matlib MA.

J Card Fail. 1999 Dec;5(4):324-33.PMID: 10634674 [PubMed - indexed for MEDLINE]Related articles

Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy.

Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, Bader M, Schultheiss HP, Tschöpe C.

Diabetes. 2009 Jun;58(6):1373-81. Epub 2009 Mar 10.PMID: 19276445 [PubMed - indexed for MEDLINE]Related articlesFree article

The cardiac neural stem cell phenotype is compromised in streptozotocin-induced diabetic cardiomyopathy.

El-Helou V, Proulx C, Béguin P, Assimakopoulos J, Gosselin H, Clement R, Villeneuve L, Huot-Marchand JE, Deblois D, Lajoie C, Calderone A.

J Cell Physiol. 2009 Aug;220(2):440-9.PMID: 19388005 [PubMed - indexed for MEDLINE]Related articles

The angiotensin-(1-7) receptor agonist AVE0991 is cardioprotective in diabetic rats.

Ebermann L, Spillmann F, Sidiropoulos M, Escher F, Heringer-Walther S, Schultheiss HP, Tschöpe C, Walther T.

Eur J Pharmacol. 2008 Aug 20;590(1-3):276-80. Epub 2008 May 24.PMID: 18571157 [PubMed - indexed for MEDLINE]Related articles

Human apolipoprotein A-I gene transfer reduces the development of experimental diabetic cardiomyopathy.

Van Linthout S, Spillmann F, Riad A, Trimpert C, Lievens J, Meloni M, Escher F, Filenberg E, Demir O, Li J, Shakibaei M, Schimke I, Staudt A, Felix SB, Schultheiss HP, De Geest B, Tschöpe C.

Circulation. 2008 Mar 25;117(12):1563-73. Epub 2008 Mar 10.PMID: 18332268 [PubMed - indexed for MEDLINE]Related articlesFree article

Effects of ACE-I on diabetic cardiovascular complications: anti-hypertensive and non-antihypertensive doses.

Udayachalerm W, Vechakarn O, Patumraj S.

J Med Assoc Thai. 2001 Jun;84 Suppl 1:S306-13.PMID: 11529349 [PubMed - indexed for MEDLINE]Related articles

Low-dose treatment with atorvastatin leads to anti-oxidative and anti-inflammatory effects in diabetes mellitus.

Riad A, Du J, Stiehl S, Westermann D, Mohr Z, Sobirey M, Doehner W, Adams V, Pauschinger M, Schultheiss HP, Tschöpe C.

Eur J Pharmacol. 2007 Aug 27;569(3):204-11. Epub 2007 May 24.PMID: 17669395 [PubMed - indexed for MEDLINE]Related articles

The influence of sulindac on diabetic cardiomyopathy: a non-invasive evaluation by Doppler echocardiography in streptozotocin-induced diabetic rats.

Krishna KM, Gopal GS, Chalam CR, Madan K, Kumar VK, Prakash GJ, Annapurna A.

Vascul Pharmacol. 2005 Aug;43(2):91-100.PMID: 15996900 [PubMed - indexed for MEDLINE]Related articles

Role of inducible nitric oxide synthase in induction of RhoA expression in hearts from diabetic rats.

Soliman H, Craig GP, Nagareddy P, Yuen VG, Lin G, Kumar U, McNeill JH, Macleod KM.

Cardiovasc Res. 2008 Jul 15;79(2):322-30. Epub 2008 Apr 14.PMID: 18411229 [PubMed - indexed for MEDLINE]Related articlesFree article